Alternating Bioactivity of Polymeric Layer-by-Layer Assemblies:  Anticoagulation vs Procoagulation of Human Blood

Abstract

The layer-by-layer assembly between cationic chitosan and anionic dextran sulfate was analyzed quantitatively by a quartz crystal microbalance technique in the absence and presence of 0.2, 0.5, and 1 M NaCl in the polymer solution. The apparent film thickness increased upon increasing the NaCl concentration. The anti- versus procoagulant activity of these films against whole human blood was studied by the immersion of a substrate into blood for 30 min incubation time at 37 degrees C. The substrate was coated with films of varying NaCl concentrations and assembly step numbers. There was a critical concentration for the alternating activity; above a concentration of 0.5 M NaCl, both anti- and procoagulation could be observed on the dextran sulfate and chitosan surfaces, respectively. The underlying layer of the assembly was necessary for this alternating activity; after a five-step assembly, the activity was realized. The adsorption of a cationic dye (methylene blue) onto the films revealed that the anionic-charge density derived from dextran sulfate on the film surface was linearly increased with increased NaCl concentration. There was a critical charge density of the dextran sulfate for the anticoagulant activity. An assembly was also constructed from a combination of chitosan and heparin, but the activity was different from that of the former system; strong anticoagulant activity was observed even on the chitosan surface. We suggest that the polymer species and/or the assembly conditions are key factors for realizing the alternating bioactivities of films prepared by the layer-by-layer assembly.

Polyelectrolyte Multilayer Films of Controlled Stiffness Modulate Myoblast Cell Differentiation

“…These surface coatings can be deposited easily on biomaterial surfaces and have versatile properties. First, their bulk and surface chemistry can be modulated by carefully choosing the type of polymer used in the buildup and the film end-layer [19] [20] [21] . Second, their "bulk" mechanical properties can be modulated, either by incorporation of nanocolloids in the films [22] , building films at different pH for a given polycation/polyanion pair [11] , or covalently cross-linking the films using [23] .…”

Tamibarotene-loaded citric acid-crosslinked alkali-treated collagen matrix as a coating material for a drug-eluting stent

“…The antithrombogenic properties of the matrices were evaluated according to established methods [28,29]. Each matrix was pre-incubated in 0.1 M phosphate buffered saline (PBS) for 24 h, then placed in a tube and immersed in 1 ml of arterial porcine whole blood for 30 min at 37…”

Biocompatible polypeptide microcapsules via templating mesoporous silica spheres

“…polypeptides (e.g., PLL, PGA) [11][12][13][14]. For example, multilayer films of dextran/chitosan have the properties of pro-or anti-coagulation depending on the outmost layer of the film [11].…”

“…For example, multilayer films of dextran/chitosan have the properties of pro-or anti-coagulation depending on the outmost layer of the film [11]. In a recent study, Picart et al reported that the cell adhesive behaviour could be controlled by the structure and architecture of PLL/PGA multilayer films, which could be tuned by varying the pH values during film preparation [13].…”